Clinical Trial Update: NDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-Iberdomide [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating extended VRD, Isa-VRD, and Isa-V-Iberdomide for newly diagnosed multiple myeloma patients candidates for autologous stem cell transplan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Isa-V-Iberdomide
• Isa-VRD
• extended VRD

Snippet

Sponsor: PETHEMA Foundation | Conditions: Newly Diagnosed Multiple Myeloma | Phase 3 | Status: NOT_YET_RECRUITING